SAN RAMON, Calif., June 15, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) announced today the publication of its first Environmental, Social, and Governance (ESG) Report, highlighting the Company’s progress on ESG items most important to its businesses and stakeholders, including employees, shareholders, customers, and global communities.

“At Cooper, we believe operating with integrity and conducting our business in a socially and environmentally responsible manner is important to our long-term success. We are proud of our ESG progress and committed to accomplishing more,” said Al White, President and CEO of CooperCompanies (“Cooper”).

Cooper’s 2020 ESG Report details its commitment to bringing health and vision care to more people worldwide through ethical business practices and innovative, high-quality products. It includes the Company’s approach and progress on key ESG priority issues identified during a recent materiality assessment, including product quality and patient safety; business ethics; employee health and safety; diversity and inclusion; and human capital management. In developing the report, Cooper aligned with the Sustainability Accounting Standards Board (SASB) standards.
Key report highlights include:

Cooper’s mission of improving lives one person at a time is grounded in enhancing the health and wellness of people and communities across the globe. The company aligned our commitments with United Nations Sustainable Development Goals (“SDGs”), in particular with three SDG’s that most closely connect with its business: #3 Good Health and Well-being, #12 Responsible Consumption and Production, and #17 Partnerships.

Read more in the Cooper 2020 Environmental, Social, and Governance Report: https://www.coopercos.com/esg-report-2020/

About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE: COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, CA, Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.

Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com